In January, the Federal Trade Commission issued the second interim report related to its investigation of the PBM industry with a focus on the most commonly prescribed high-cost specialty generic drugs. Some interesting findings...
The Federal Trade Commission has been investigating the PBM industry and last July issued the first interim report on its findings, take a listen...
#PBM #ThePBMInsider #PrescriptionNetwork #letustakecareofyou #PBMdoneright
Welcome to the inaugural edition of The PBM Insider, providing insights and education regarding prescription benefits management and how it works in the US today.
Rebates. One of the most confusing features in the PBM industry. In this edition, I'll talk about their history and make an argument for why they should go away. Take a listen...
Our VP of Client Services, Karon Lee, discusses Prescription Network’s flexibility.
Our VP of Client Services, Karon Lee, discusses Prescription Network’s Gap Plan.